Medication Adherence and FDA: A Q&A With Safe Use Head
This article was originally published in RPM Report
Executive Summary
One of the many stakeholders involved with the National Consumers League’s adherence campaign is FDA, through CDER’s Safe Use Initiative, CDER’s Office of Communication and FDA’s Office of Women’s Health. Here is an email Q&A with Safe Use Initiative Director Karen Weiss for more details on FDA’s role in Script Your Future and medication adherence more broadly.
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.